Blog

Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.

Open filters
Search
Tags
Author
Aditi Singhai
Alison Sathe
Anders Vinther
Anne-Caroline Boillot
Barbara W. Unger
Barry Price
Jackie Torfin
Jerry Chapman
Jon Falker
Katie Terry
Khushboo Agrawal
Mark Agostino
Michael de la Torre
Rebecca Stauffer
Redica Systems
Roger Angarita
Sarah Boynton
Scott Sherrill
Tashil Sharma
Subscribe to our Newsletter
Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.
Trends

What All API Manufacturers Need to Know

No items found.

On-Demand Webinar: GMP Compliance Issues for Legacy Products

No items found.
Enforcement

Warning Letters Week of 11/10/2019: Continued Sartan Enforcement

No items found.

October 483s: Most Popular and Newsworthy

No items found.
Enforcement

FDA Warning Letters Week of 11/3/2019: Lost Documentation and Data Integrity

No items found.
Conference Spotlight

How Key Pharma and Device Executives Are Developing the Next Generation of Quality Professionals and Leaders

No items found.
Enforcement

FDA Warning Letters Week of 10/27/2019: Sterility and Spores

No items found.
Conference Spotlight

Office of Combination Products Official Details Rulemaking and Guidance Agenda

No items found.

Repeat Deficiencies in Lupin Limited Warning Letters

No items found.
Conference Spotlight

FDA Expanding its Sterile Drug NIPP Inspection Pilot to Include Other Dosage Forms

No items found.
Conference Spotlight

Part 2: How Amgen Uses AI Tools To Improve Manufacturing Deviation Investigations

No items found.

Introducing Jonathan Rochez, Redica Systems’s New VP of Engineering

No items found.
Enforcement

CTP Issues First-of-a-Kind Warning Letter to JUUL Labs

No items found.
Conference Spotlight

Part 1: How Amgen Uses AI Tools To Improve Manufacturing Deviation Investigations

No items found.
Trends

Identification of Software Validation Shortcomings

No items found.

Gaining GMP Expertise: Govzilla Adds Jane Wastl as Senior GMP Quality Expert

No items found.
Trends

Recent Statement Regarding ARB Recalls

No items found.

AveXis’s New Gene Therapy Approved but New Questions Are Raised

No items found.